Other Clinical Trial - Efficacy & Safety Study of ABP 215 Compared With

See also
Status	Clinical Trial	Phase
Completed	`NCT01523340` - A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response
Recruiting	`NCT03956641` - Evolution of the Physical Condition in Treated Cancer Patients	N/A
Active, not recruiting	`NCT02035683` - PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy	N/A
Completed	`NCT01848613` - Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC	Phase 4
Suspended	`NCT01320501` - Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer	Phase 4
Terminated	`NCT01471964` - Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer	Phase 1/Phase 2
Recruiting	`NCT06127940` - K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation	Phase 1
Terminated	`NCT04069936` - Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC	Phase 2
Terminated	`NCT03445000` - ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung Cancer	Phase 2
Terminated	`NCT03386929` - Survival Prolongation by Rationale Innovative Genomics	Phase 1/Phase 2
Recruiting	`NCT02922764` - A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer	Phase 1
Terminated	`NCT01574300` - Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Active, not recruiting	`NCT04646824` - Almonertinib With Chemotherapy in mEGFR NSCLC	Phase 2
Recruiting	`NCT03656094` - Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 Inhibitors	Phase 2
Terminated	`NCT01348126` - Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer	Phase 2/Phase 3
Active, not recruiting	`NCT03469960` - Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr	Phase 3
Recruiting	`NCT05919264` - FOG-001 in Locally Advanced or Metastatic Solid Tumors	Phase 1/Phase 2
Completed	`NCT04793815` - Lung Cancer Cryo-Activation as a Novel Approach to Augment Immunotherapy Efficacy (CRYOVATE)	N/A
Terminated	`NCT01380795` - Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial Carcinomas	Early Phase 1
Completed	`NCT02959619` - Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK	Phase 1

NCT number	NCT01966003
Study type	Interventional
Source	Amgen
Contact
Status	Completed
Phase	Phase 3
Start date	November 11, 2013
Completion date	July 23, 2015

Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms